Extensive Drug Resistance in Intensive Care Units, Yemen, 2021: A Cross-Sectional Study

Authors

  • Samar Saeed Nasher
  • Sameer. A. A. Qasem
  • Talal Y. Al Qahtani
  • Abdul Wahed A. Al Serouri

DOI:

https://doi.org/10.54582/TSJ.2.2.81

Keywords:

Antimicrobial Drug-Resistant, Nosocomial Infections, Intensive Care Units, Gram-Negative bacilli, Yemen

Abstract

The emergence of nosocomial infections (NCI) in Intensive care units (ICUs) that caused by antimicrobial Drug Resistance (AMR) Gram-Negative bacilli (GNB) has become a major public health threat since there is a limited effective treatment. This study is aimed to determine the Prevalence Rate of NCI, and the antibiotic susceptibility pattern of isolates. A cross-sectional study was conducted in six adult ICUs at Al Thawra General hospital, Sana’a, Yemen. A total of 117 admitted patients were included in the study from the period of 1st August to 31st October 2021. A pre-designed questionnaire was used for the collection of socio-demographic and clinical data, various clinical specimens were collected from NCI patients and processed using Vitek 2 automated system to identify the isolates and its susceptibility pattern. Carbapenemase producing was tested by Imipenem-EDTA synergy disc diffusion test according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Data were analyzed using Epi-info version 7.2 statistical software packages (CDC, USA), and the results were presented as descriptive statistics: rates & frequency for categorical variables while, mean ±SD or\medium (minimum –maximum) for quantitative variables. The prevalence of NCI in ICUs was 46%. The most isolates were GNB (88%, 52/59). K pneumoniae was the most prevalent (37%, 19/52) while, P aeruginosa and A baumannii were the most resistant. The resistance for tested antibiotics was 98% (51/52) of isolates; 75% of them showed Extensive Drug Resistance (XDR), and 47% were Carbapenemase producers. However, most AMR-GNB is still susceptible to Polymyxin B and Colistin, the resistance has found to be 10% and 12 % respectively. The high prevalence of AMR-NCI in ICUs calls for an urgent establishment of a stewardship program with strict measures of Infection Prevention Control and regular monitoring of the resistant strains.

Downloads

Published

2024-05-24

How to Cite

Nasher, S. S., Qasem, S. A. A., Al Qahtani, T. Y., & Al Serouri, A. W. A. (2024). Extensive Drug Resistance in Intensive Care Units, Yemen, 2021: A Cross-Sectional Study. The Scientific Journal of University of Saba Region, 6(2). https://doi.org/10.54582/TSJ.2.2.81

Issue

Vol. 6 No. 2 (2024)

Section

المقالات

License

Copyright and Licensing

This journal publishes all scientific materials under the Creative Commons Attribution 4.0 International (CC BY 4.0) , license, which grants you the following permissions:

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.